July 27, 2017 1:38 PM ET

Professional Services

Company Overview of Biologics Consulting Group, Inc.

Company Overview

Biologics Consulting Group, Inc. provides regulatory and product development consulting services. The company offers clinical trials planning and consulting, medical writing, electronic publishing and submission, staff augmentation, and due diligence services. It caters to multinational pharmaceutical, biotechnology, and medical device companies; academic and research institutions; and small biotechnology and medical device start-ups. Biologics Consulting Group, Inc. was founded in 1993 and is headquartered in Alexandria, Virginia.

400 North Washington Street

Suite 100

Alexandria, VA 22314

United States

Founded in 1993





Key Executives for Biologics Consulting Group, Inc.

Chief Executive Officer and President
Founder and Chairman
Chief Financial Officer and Vice President of Finance
Chief Legal officer
Director Pharmacology-Toxicology and Senior Consultant
Compensation as of Fiscal Year 2017.

Biologics Consulting Group, Inc. Key Developments

Biologics Consulting Group, Inc. Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017

Biologics Consulting Group, Inc. Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017 . Venue: HILTON SAN FRANCISCO UNION SQUARE, 333 O'Farrell Street, San Francisco, CA 94102, United States.

Imaging3, Inc. Announces Execution of Consulting Service Agreement with Biologics Consulting Group, Inc

Imaging3, Inc. announced that on September 26, 2016 it has signed a consulting services agreement with Biologics Consulting Group, Inc. of Alexandria, VA, by which the company agrees to provide consulting services to manage the planning for and drafting of the Imaging3’s 510K application for its Volumetric Imaging Scanner for submission to the United States Food and Drug Administration. On October 3, 2016, the company accepted the first work order under the Agreement. Imaging3, Inc. retained the company in 2011 to review 510K submission of 2009 after it was denied by the FDA in March, 2010. After discussions to determine why the 2009 510K application was denied and wheth er the concerns that caused the FDA to issue such denial could be remedied in a new filing, the company and Imaging3, Inc. determined that such matters could be addressed in a new, strategically prepared and detailed application which could support FDA approval. On September 8, 2011, with substantial research and preparation, the company submitted a Pre–IDE request to initiate the process of the new FDA application. This effort was thwarted by the financial issues which led to the company’s bankruptcy filing in September 2012.

Similar Private Companies By Industry

Company Name Region
1-2-3 Payroll & HR Services, Inc. United States
120 Water Audit, LLC United States
123College.com, Inc. United States
13D Research LLC United States
1410 Partners, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biologics Consulting Group, Inc., please visit www.biologicsconsulting.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.